These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32021873)

  • 1. A Novel
    Gao E; Yang X; Si N; Liu K; Wang JQ; Liu Z
    Kidney Dis (Basel); 2020 Jan; 6(1):43-49. PubMed ID: 32021873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal mRNA Splicing Effect of
    Zhang Y; Wang X; Zhou J; Ding J; Wang F
    Kidney Int Rep; 2023 Jul; 8(7):1399-1406. PubMed ID: 37441478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
    Liang L; Wu H; Cai Z; Zhao J
    BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of
    Liang L; Wu H; Cai Z; Zhao J
    Front Genet; 2023; 14():1059322. PubMed ID: 36923787
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family.
    Chen S; Xu G; Zhao Z; Du J; Shen B; Li C
    BMC Med Genomics; 2024 Apr; 17(1):108. PubMed ID: 38671472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay.
    Zhang R; Lang Y; Shi X; Zhang Y; Liu X; Pan F; Qiao D; Teng X; Shao L
    Mol Genet Genomic Med; 2024 Feb; 12(2):e2395. PubMed ID: 38400605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deep intronic splice variant of the
    Qian P; Bao Y; Huang HM; Suo L; Han Y; Li ZJ; Zhang M
    Front Pediatr; 2022; 10():1009188. PubMed ID: 36714647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Splicing of
    Li Y; Yan X; Luo Z; Fu X; Li Z; Xu Q; Chen J; Yang J; Lu D
    Int J Nephrol Renovasc Dis; 2024; 17():167-174. PubMed ID: 38855711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disease-causing variant of COL4A5 in a Chinese family with Alport syndrome: a case series.
    Wu J; Zhang J; Liu L; Zhang B; Yamamura T; Nozu K; Matsuo M; Zhao J
    BMC Nephrol; 2021 Nov; 22(1):380. PubMed ID: 34774011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families.
    Lv X; Wu WQ; Zhang JX; Miao LF; Yu BZ; Chen FF; Cui YX; Xia ZK; Liu ZH; Li XJ
    Cytogenet Genome Res; 2020; 160(5):238-244. PubMed ID: 32659759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assessment of a novel
    Chen X; Ye N; Zhang L; Zheng W; Cheng J; Gong M
    Ann Transl Med; 2021 Sep; 9(18):1420. PubMed ID: 34733972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of four novel mutations in the
    Zhao X; Shang X; Chen C; Liu L; Wang C; Zhao G; Zhang J; Kong X
    Biomed Rep; 2020 Aug; 13(2):4. PubMed ID: 32607233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the pathogenicity of a novel COL4A5 missense variant by CRISPR-Cas9 in kidney podocytes.
    Sun L; Hao S; Kuang XY; Wu Y; Huang WY
    Am J Transl Res; 2021; 13(8):9086-9094. PubMed ID: 34540022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Kaito H; Matsuo M; Iijima K
    Sci Rep; 2019 Sep; 9(1):12696. PubMed ID: 31481700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.